Breaking News Instant updates and real-time market news.

VRTX

Vertex

$179.00

-6.46 (-3.48%)

07:57
10/19/18
10/19
07:57
10/19/18
07:57

Vertex receives European CHMP positive opinion for KALYDECO

Vertex Pharmaceuticals announces that the European Medicines Agency's Committee for Medicinal Products for Human Use adopted a positive opinion for KALYDECO to include the treatment of people with cystic fibrosis aged 12 to less than24 months who have at least one of the following nine mutations in their cystic fibrosis transmembrane conductance regulator gene: G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. If the European Commission issues a favorable adoption of the EMA CHMP opinion for the extension of indication, ivacaftor will be the first and only medicine approved in Europe to treat the underlying cause of CF in patients aged 12 to less than24 months, who have specific mutations in the CFTR gene. The submission was supported by data from the ongoing Phase 3 open-label safety study of children with CF aged 12 to less than24 months who have one of 10 mutations in the CFTR gene that demonstrated a safety profile consistent with that observed in previous Phase 3 studies of older children and adults, and improvements in sweat chloride, a key secondary efficacy endpoint. Ivacaftor is already approved in Europe for the treatment of CF in patients aged two years and older who have one of the nine following mutations in the CFTR gene: G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. It is also approved for the treatment of CF in patients aged 18 years and older who have an R117H mutation in the CFTR gene.

  • 22

    Oct

  • 24

    Oct

VRTX Vertex
$179.00

-6.46 (-3.48%)

10/01/18
CANT
10/01/18
INITIATION
Target $217
CANT
Overweight
Vertex initiated with an Overweight at Cantor Fitzgerald
Cantor Fitzgerald analyst Alethia Young started Vertex Pharmaceuticals with an Overweight rating and $217 price target.
10/11/18
JEFF
10/11/18
NO CHANGE
Target $210
JEFF
Buy
Jefferies sees shares of Vertex 'going back up and recovering'
Shares of Vertex Pharmaceuticals (VRTX) have pulled back from recent highs of $190-$195 down to $175 on "risk-off rotation" amid the broader market selloff, Jefferies analyst Michael Yee tells investors in a research note. However, nothing fundamental has happened and Vertex still has the "cleanest growth story in large biotech," Yee contends. The triple pill has confirmed Phase III pivotal data coming Q4 and upcoming competitor Galapagos NV (GLPG) data "probably will eventually disappoint," claims the analyst. He also views CTX001 coming off clinical hold as a "nice positive" and thinks the company's pipeline is likely to start garnering more focus over the next 6-12 months. Yee sees the stock "eventually going back up and recovering" and keeps a Buy rating on Vertex with a $210 price target.
10/18/18
RBCM
10/18/18
UPGRADE
Target $9
RBCM
Outperform
Proteostasis upgraded to Outperform at RBC Capital on positive CF data
As reported earlier, RBC Capital analyst Brian Abrahams upgraded Proteostasis (PTI) to Outperform from Sector Perform and also raised his price target to $9 from $4 following an "impressive" set of data from its phase 2 cystic fibrosis doublet trial. The analyst notes that while it is too soon to determine if it will pose a "competitive threat to developmental CFTR modulators marketed by Vertex Pharma (VRTX), the trial showed "clean, consistent, dose-dependent lung function improvements".
10/18/18
MSCO
10/18/18
NO CHANGE
MSCO
Overweight
Vertex weakness on competitor data an overreaction, says Morgan Stanley
Morgan Stanley analyst Matthew Harrison attributes weakness in shares of Vertex (VRTX) to the fact that potential competitor Proteostasis (PTI) released initial Phase 1 data showing that its doublet achieved a roughly 6% increase in FEV1 in the highest dose, compared with about 5% for the VX-661 doublet in Phase 1/2. However, he would caution over-interpretation of the results, noting that Proteostasis' data includes only about five patients per arm; the high mean FEV1 increase may be the result of a "super-responder"; and doublet data "isn't meaningful given triplets with 10-15% FEV1 improvement will be the new standard of care." The analyst, who sees Vertex's sizeable lead and robust data limiting any competitive risks, keeps an Overweight rating on Vertex shares, which are down about 4% in morning trading.

TODAY'S FREE FLY STORIES

XOM

Exxon Mobil

$82.49

-0.9 (-1.08%)

10:01
04/24/19
04/24
10:01
04/24/19
10:01
Hot Stocks
Exxon Mobil to expand Fawley refinery in United Kingdom »

ExxonMobil said that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

RES

RPC, Inc.

$11.59

-1.31 (-10.16%)

10:00
04/24/19
04/24
10:00
04/24/19
10:00
Hot Stocks
RPC, Inc. falls -10.0% »

RPC, Inc. is down -10.0%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 08

    May

  • 09

    May

  • 13

    Nov

SPN

Superior Energy

$4.42

-0.545 (-10.98%)

10:00
04/24/19
04/24
10:00
04/24/19
10:00
Hot Stocks
Superior Energy falls -10.1% »

Superior Energy is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

LRN

K12

$31.01

-5.215 (-14.40%)

10:00
04/24/19
04/24
10:00
04/24/19
10:00
Hot Stocks
K12 falls -13.7% »

K12 is down -13.7%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAP

SAP

$129.21

14.37 (12.51%)

10:00
04/24/19
04/24
10:00
04/24/19
10:00
Hot Stocks
SAP rises 12.5% »

SAP is up 12.5%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 07

    May

TRK

Speedway Motorsports

$18.09

4.11 (29.40%)

10:00
04/24/19
04/24
10:00
04/24/19
10:00
Hot Stocks
Speedway Motorsports rises 29.9% »

Speedway Motorsports is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

MPX

Marine Products

$15.49

1.46 (10.41%)

10:00
04/24/19
04/24
10:00
04/24/19
10:00
Hot Stocks
Marine Products rises 13.8% »

Marine Products is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

AMRN

Amarin

$18.08

-0.31 (-1.69%)

09:59
04/24/19
04/24
09:59
04/24/19
09:59
Recommendations
Amarin analyst commentary  »

Jefferies sees potential…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 01

    May

  • 06

    May

APC

Anadarko

$71.16

7.04 (10.98%)

, PCG

PG&E

$22.35

0.89 (4.15%)

09:55
04/24/19
04/24
09:55
04/24/19
09:55
Options
Early notable gainers among liquid option names on April 24th »

Notable gainers among…

APC

Anadarko

$71.16

7.04 (10.98%)

PCG

PG&E

$22.35

0.89 (4.15%)

TEL

TE Connectivity

$93.81

4.01 (4.47%)

NSC

Norfolk Southern

$210.59

8.91 (4.42%)

EBAY

eBay

$38.38

1.72 (4.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 24

    Apr

  • 07

    May

  • 09

    May

  • 14

    May

  • 22

    May

  • 29

    May

  • 05

    Jun

SMGZY

Smiths Group

$0.00

(0.00%)

, SMGKF

Smiths Group

$0.00

(0.00%)

09:53
04/24/19
04/24
09:53
04/24/19
09:53
Conference/Events
Smiths Group management to meet with JPMorgan »

Meeting to be held in…

SMGZY

Smiths Group

$0.00

(0.00%)

SMGKF

Smiths Group

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

APH

Amphenol

$96.54

-8.86 (-8.41%)

09:53
04/24/19
04/24
09:53
04/24/19
09:53
Recommendations
Amphenol analyst commentary at Morgan Stanley »

Amphenol selloff a buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 24

    Apr

  • 22

    May

FDX

FedEx

$195.15

0.02 (0.01%)

09:51
04/24/19
04/24
09:51
04/24/19
09:51
Conference/Events
FedEx management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 29

    Apr

  • 07

    May

  • 03

    Jun

  • 25

    Jun

  • 13

    Nov

ENFC

Entegra Financial

$23.72

(0.00%)

09:50
04/24/19
04/24
09:50
04/24/19
09:50
Hot Stocks
Breaking Hot Stocks news story on Entegra Financial »

Entegra Financial trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OXY

Occidental Petroleum

$60.74

-1.61 (-2.58%)

09:50
04/24/19
04/24
09:50
04/24/19
09:50
Options
Opening call buyers in Occidental Pete as shares drop 3% »

Opening call buyers in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

  • 10

    May

  • 29

    May

LPL

LG Display

$8.59

-0.895 (-9.44%)

09:47
04/24/19
04/24
09:47
04/24/19
09:47
Hot Stocks
LG Display falls -9.2% »

LG Display is down -9.2%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APH

Amphenol

$94.96

-10.44 (-9.91%)

09:47
04/24/19
04/24
09:47
04/24/19
09:47
Hot Stocks
Amphenol falls -9.7% »

Amphenol is down -9.7%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 24

    Apr

  • 22

    May

RES

RPC, Inc.

$11.43

-1.47 (-11.40%)

09:47
04/24/19
04/24
09:47
04/24/19
09:47
Hot Stocks
RPC, Inc. falls -12.0% »

RPC, Inc. is down -12.0%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 08

    May

  • 09

    May

  • 13

    Nov

SAP

SAP

$126.94

12.1 (10.54%)

09:47
04/24/19
04/24
09:47
04/24/19
09:47
Hot Stocks
SAP rises 10.5% »

SAP is up 10.5%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 07

    May

TRK

Speedway Motorsports

$18.00

4.02 (28.76%)

09:47
04/24/19
04/24
09:47
04/24/19
09:47
Hot Stocks
Speedway Motorsports rises 28.8% »

Speedway Motorsports is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

APC

Anadarko

$71.57

7.45 (11.62%)

09:47
04/24/19
04/24
09:47
04/24/19
09:47
Hot Stocks
Anadarko rises 11.8% »

Anadarko is up 11.8%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

  • 22

    May

IFRX

InflaRx

$51.42

(0.00%)

09:43
04/24/19
04/24
09:43
04/24/19
09:43
Recommendations
InflaRx analyst commentary at BMO Capital »

InflaRx price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OXY

Occidental Petroleum

$62.35

(0.00%)

, SNAP

Snap

$11.99

(0.00%)

09:40
04/24/19
04/24
09:40
04/24/19
09:40
Options
Unusually active option classes on open April 24th »

Unusual total active…

OXY

Occidental Petroleum

$62.35

(0.00%)

SNAP

Snap

$11.99

(0.00%)

APC

Anadarko

$64.12

(0.00%)

T

AT&T

$32.11

(0.00%)

TXN

Texas Instruments

$116.37

(0.00%)

EBAY

eBay

$36.66

(0.00%)

SIRI

Sirius XM

$6.14

(0.00%)

CAT

Caterpillar

$142.08

(0.00%)

BX

Blackstone

$39.72

(0.00%)

TWTR

Twitter

$39.76

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 25

    Apr

  • 26

    Apr

  • 06

    May

  • 07

    May

  • 07

    May

  • 10

    May

  • 14

    May

  • 18

    May

  • 20

    May

  • 20

    May

  • 22

    May

  • 23

    May

  • 29

    May

  • 11

    Jun

  • 12

    Jun

09:40
04/24/19
04/24
09:40
04/24/19
09:40
General news
Treasury 5-year auction outlook: the $41 B continues to richen »

Treasury 5-year auction…

HAS

Hasbro

$100.34

12.32 (14.00%)

09:39
04/24/19
04/24
09:39
04/24/19
09:39
Recommendations
Hasbro analyst commentary at SunTrust »

Hasbro price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

  • 29

    May

AMKR

Amkor Technology

$9.03

0.13 (1.46%)

09:38
04/24/19
04/24
09:38
04/24/19
09:38
Hot Stocks
Amkor Technology early strength attributed to speculation of Apple win »

An analyst is supposedly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 15

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.